Perfectus Biomed Group are leaders in standard and customized microbiology testing services for a variety of sectors, including wound care, medical devices, infectious disease, and disinfectants and biocides.
From our laboratories we support your outsourced microbiology including virology, bacteriology and molecular services, regulatory submissions, product efficacy testing, research and development and claims substantiation.
Our UK facility is a GLP-compliant and UKAS accredited ISO 17025 contract testing laboratory and we also hold ISO 9001 certification. We are governed by the MHRA, UKAS and BSI and perform testing that meets the multiple regulatory requirements for CA and CE marks, and the new MDR/PMS European regulations.
BACTERIOLOGY
Offering standard and customized microbiology, including accredited biofilm test methods. Supporting antibacterial and antimicrobial product claims
CELL BIOLOGY
Offering biocompatibility testing to support the biological evaluation of medical devices.
What our customers say
TESTING SERVICES
Perfectus Biomed specializes in novel antimicrobial assays, performing customized methodologies and supporting clients through regulatory approval processes such as FDA 510(K) submissions, New Drug Applications (NDAs) and Pre IND applications.
Our dedicated team, offer Research and Development projects, GLP compliant testing and ISO 17025 testing within a time efficient, client focused approach. Our expertise and knowledge are fundamental to the services we provide.
SERVICES
|
|
SECTORS
|
|
New Standard Notification – ISO 4768:2023
New Standard Notification – ISO 4768:2023 the measurement of anti-biofilm activity on plastic and other non-porous surfaces was released this month.
This marks a key progressive step in anti-biofilm testing standards. The method is to support material development and...
Testing Solutions to Support Medical Device Innovation
New and novel products are a necessity in the medical device market. Industry investment in innovation delivers life enhancing healthcare devices, diagnostics, and digital solutions. Hand-in-hand with product innovation is its innovative test methods, to support efficacy...
Biofilm Spotlight Interview – Dr Philip Bowler
We are once again supporting the NBIC Biofilm Week 2022 campaign, highlighting research to prevent, detect, manage, and engineer biofilms.
Perfectus Biomed Group, now part of NAMSA, are thrilled to take this opportunity to launch our Biofilm Spotlight Interview Series....